Home/Filings/4/0001104659-22-105844
4//SEC Filing

PFREUNDSCHUH PETER P. 4

Accession 0001104659-22-105844

CIK 0001640266other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 4:15 PM ET

Size

5.6 KB

Accession

0001104659-22-105844

Insider Transaction Report

Form 4
Period: 2022-10-01
PFREUNDSCHUH PETER P.
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-10-01+125,000125,000 total
Footnotes (2)
  • [F1]This equity award was not granted pursuant to any pre-existing equity incentive plan of Voyager Therapeutics, Inc. (the "Company"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4).
  • [F2]Consists of shares of common stock underlying a restricted stock unit ("RSU") award. Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is October 1, 2022. The RSU award vests over three years, with 33.333% of the shares of common stock underlying the RSU award vesting upon the one-year anniversary of such vesting commencement date and the remainder vesting in equal annual installments thereafter, subject to the Reporting Person's continued service as an employee.

Issuer

Voyager Therapeutics, Inc.

CIK 0001640266

Entity typeother

Related Parties

1
  • filerCIK 0001585839

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:15 PM ET
Size
5.6 KB